168 related articles for article (PubMed ID: 2533953)
21. Inhibitory effect of ubiquinone on biosynthesis of aldosterone in rat adrenal in vitro.
Kumagai A; Nishino K; Kimm T; Shimomura A; Nanahoshi M; Yamamura Y
Endocrinol Jpn; 1970 Apr; 17(2):143-8. PubMed ID: 5468812
[No Abstract] [Full Text] [Related]
22. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
Nishino Y; Schneider MR; Michna H; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
Tanaka M; Yano S; Hasegawa Y; Nakao K
Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
[TBL] [Abstract][Full Text] [Related]
24. The effect of puromycin on the biosynthesis of aldosterone in isolated adrenal mitochondria.
Marusic ET; Mulrow PJ
Endocrinology; 1972 Oct; 91(4):1125-9. PubMed ID: 4403259
[No Abstract] [Full Text] [Related]
25. Met-enkephalin inhibits mineralocorticoid production in isolated human aldosteronoma cells.
Rácz K; Varga I; Gláz E; Kiss R; Vida S; Lada G; di Gleria K; Medzihradszky K; Lichtwald K; Vecsei P
J Clin Endocrinol Metab; 1982 Mar; 54(3):656-60. PubMed ID: 7056849
[TBL] [Abstract][Full Text] [Related]
26. [Biosynthesis pathways for aldosterone and its precursors in the tissue of the capsular portion of the rat adrenals].
Iudaev NA; Druzhinina KV
Probl Endokrinol (Mosk); 1974; 20(4):71-5. PubMed ID: 4375284
[No Abstract] [Full Text] [Related]
27. Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.
Houjou T; Wada T; Yasutomi M
Clin Ther; 1993; 15(1):137-47. PubMed ID: 8458043
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of estrogen biosynthesis and its consequences on gonadotrophin secretion in the male.
Bhatnagar AS; Müller P; Schenkel L; Trunet PF; Beh I; Schieweck K
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):437-43. PubMed ID: 1532903
[TBL] [Abstract][Full Text] [Related]
29. Effect of beta-lipotropin on aldosterone production in the isolated rat adrenal cell preparation.
Washburn DD; Kem DC; Orth DN; Nicholson WE; Chrétien M; Mount CD
J Clin Endocrinol Metab; 1982 Mar; 54(3):613-8. PubMed ID: 7056844
[TBL] [Abstract][Full Text] [Related]
30. Conversion of 11-deoxycorticosterone and corticosterone to aldosterone by cytochrome P-450 11 beta-/18-hydroxylase from porcine adrenal.
Yanagibashi K; Shackleton CH; Hall PF
J Steroid Biochem; 1988 Jun; 29(6):665-75. PubMed ID: 3386233
[TBL] [Abstract][Full Text] [Related]
31. Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients.
Dowsett M; Stein RC; Mehta A; Coombes RC
Clin Endocrinol (Oxf); 1990 May; 32(5):623-34. PubMed ID: 2142026
[TBL] [Abstract][Full Text] [Related]
32. Sites of action of sodium depletion on aldosterone biosynthesis in the dog.
Davis WW; Burwell LR; Casper AG; Bartter FC
J Clin Invest; 1968 Jun; 47(6):1425-34. PubMed ID: 4297478
[TBL] [Abstract][Full Text] [Related]
33. Adaptation of aldosterone biosynthesis to sodium and potassium intake in the rat.
Müller J; Meuli C; Schmid C; Lauber M
J Steroid Biochem; 1989; 34(1-6):271-7. PubMed ID: 2560515
[TBL] [Abstract][Full Text] [Related]
34. Effect of the intermediate filament inhibitor IDPN on steroid secretion by frog adrenal glands.
Feuilloley M; Netchitailo P; Delarue C; Leboulenger F; Benyamina M; Vaudry H
J Steroid Biochem; 1988; 30(1-6):465-7. PubMed ID: 2838700
[TBL] [Abstract][Full Text] [Related]
35. Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A.
Stein RC; Dowsett M; Davenport J; Hedley A; Ford HT; Gazet JC; Coombes RC
Cancer Res; 1990 Mar; 50(5):1381-4. PubMed ID: 2137367
[TBL] [Abstract][Full Text] [Related]
36. Corticosterone, 18-OH-deoxycorticosterone, deoxycorticosterone and aldosterone secretion in tissue culture of foetal rat adrenals in the presence and the absence of ACTH.
Salmenperä M; Kahri AI
Acta Endocrinol (Copenh); 1976 Dec; 83(4):781-93. PubMed ID: 186998
[TBL] [Abstract][Full Text] [Related]
37. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Tominaga T; Yoshida Y; Shimozuma K; Hayashi K; Kosaki G
Eur J Cancer; 1990; 26(5):600-3. PubMed ID: 2144748
[TBL] [Abstract][Full Text] [Related]
38. Pharmacology of vorozole.
Wouters W; Van Ginckel R; Krekels M; Bowden C; De Coster R
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):617-21. PubMed ID: 8386540
[TBL] [Abstract][Full Text] [Related]
39. Evidence of abnormalities in corticosteroid secretion leading to volume-dependent hypertension in Milan rats.
Fraser R; Ancil AK; Brown WB; Ingram MC; Holloway CD; Henderson IW; Kenyon CJ
Hypertension; 1994 Oct; 24(4):512-5. PubMed ID: 8088920
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the racemate and the enantiomers of a new highly active and selective aromatase inhibitor of the aminoglutethimide type.
Hartmann RW; Grün G; Bartz U; Palzer M
J Steroid Biochem Mol Biol; 1992 Dec; 43(7):641-8. PubMed ID: 1472456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
